Different Medicinal Treatment Modalities in the Management of Patent Ductus Arteriosus in Paediatric Population- A Narrative Review of Available Drug Approaches

Regardless of the size of a patient’s Patent Ductus Arteriosus (PDA), it is crucial for paediatric and adult cardiologists to have a thorough understanding of the condition’s origin, clinical ramifications, and treatment options. Possessing a PDA, no matter how little, might cause complications. Ibu...

Full description

Bibliographic Details
Main Authors: Kushal Desai, Amar Taksande
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2023-05-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://www.jcdr.net/articles/PDF/17845/63242_CE[Ra1]_F[SK]_PF1(HB_SHU)_PFA(HB_KM)_PN(KM).pdf
_version_ 1797830391332077568
author Kushal Desai
Amar Taksande
author_facet Kushal Desai
Amar Taksande
author_sort Kushal Desai
collection DOAJ
description Regardless of the size of a patient’s Patent Ductus Arteriosus (PDA), it is crucial for paediatric and adult cardiologists to have a thorough understanding of the condition’s origin, clinical ramifications, and treatment options. Possessing a PDA, no matter how little, might cause complications. Ibuprofen and indomethacin, both cyclo-oxygenase (COX) inhibitors, are used as the gold standard pharmacologic therapy for closing a PDA that has been produced surgically. These non selective COX inhibitors bring about ductal constriction, in addition to lowering the synthesis of prostaglandin. However, these drugs may also have a broad array of unintended consequences. Interest in paracetamol for PDA constriction has recently increased due to fewer adverse effects than indomethacin or ibuprofen. Evidence that paracetamol is now a topic of intense study lends credence to this hypothesis. Information on the long term effects of paracetamol is scarce in paediatric population.
first_indexed 2024-04-09T13:34:48Z
format Article
id doaj.art-2b4b4b26672847a4b59933dddecb276b
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-04-09T13:34:48Z
publishDate 2023-05-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-2b4b4b26672847a4b59933dddecb276b2023-05-09T10:37:56ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2023-05-01175SE01SE0410.7860/JCDR/2023/63242.17845Different Medicinal Treatment Modalities in the Management of Patent Ductus Arteriosus in Paediatric Population- A Narrative Review of Available Drug ApproachesKushal Desai0Amar Taksande1Postgraduate Resident, Department of Paediatrics, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India.Professor and Head, Department of Paediatrics, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India.Regardless of the size of a patient’s Patent Ductus Arteriosus (PDA), it is crucial for paediatric and adult cardiologists to have a thorough understanding of the condition’s origin, clinical ramifications, and treatment options. Possessing a PDA, no matter how little, might cause complications. Ibuprofen and indomethacin, both cyclo-oxygenase (COX) inhibitors, are used as the gold standard pharmacologic therapy for closing a PDA that has been produced surgically. These non selective COX inhibitors bring about ductal constriction, in addition to lowering the synthesis of prostaglandin. However, these drugs may also have a broad array of unintended consequences. Interest in paracetamol for PDA constriction has recently increased due to fewer adverse effects than indomethacin or ibuprofen. Evidence that paracetamol is now a topic of intense study lends credence to this hypothesis. Information on the long term effects of paracetamol is scarce in paediatric population.https://www.jcdr.net/articles/PDF/17845/63242_CE[Ra1]_F[SK]_PF1(HB_SHU)_PFA(HB_KM)_PN(KM).pdfacetaminophenibuprofenindomethacinparacetamol
spellingShingle Kushal Desai
Amar Taksande
Different Medicinal Treatment Modalities in the Management of Patent Ductus Arteriosus in Paediatric Population- A Narrative Review of Available Drug Approaches
Journal of Clinical and Diagnostic Research
acetaminophen
ibuprofen
indomethacin
paracetamol
title Different Medicinal Treatment Modalities in the Management of Patent Ductus Arteriosus in Paediatric Population- A Narrative Review of Available Drug Approaches
title_full Different Medicinal Treatment Modalities in the Management of Patent Ductus Arteriosus in Paediatric Population- A Narrative Review of Available Drug Approaches
title_fullStr Different Medicinal Treatment Modalities in the Management of Patent Ductus Arteriosus in Paediatric Population- A Narrative Review of Available Drug Approaches
title_full_unstemmed Different Medicinal Treatment Modalities in the Management of Patent Ductus Arteriosus in Paediatric Population- A Narrative Review of Available Drug Approaches
title_short Different Medicinal Treatment Modalities in the Management of Patent Ductus Arteriosus in Paediatric Population- A Narrative Review of Available Drug Approaches
title_sort different medicinal treatment modalities in the management of patent ductus arteriosus in paediatric population a narrative review of available drug approaches
topic acetaminophen
ibuprofen
indomethacin
paracetamol
url https://www.jcdr.net/articles/PDF/17845/63242_CE[Ra1]_F[SK]_PF1(HB_SHU)_PFA(HB_KM)_PN(KM).pdf
work_keys_str_mv AT kushaldesai differentmedicinaltreatmentmodalitiesinthemanagementofpatentductusarteriosusinpaediatricpopulationanarrativereviewofavailabledrugapproaches
AT amartaksande differentmedicinaltreatmentmodalitiesinthemanagementofpatentductusarteriosusinpaediatricpopulationanarrativereviewofavailabledrugapproaches